FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. - 1break

1BN-General 2022-09-30

Views 4

Bruce Rosenblum, an ALS patient and advocate, sits in his wheelchair. SOMERVILLE, Mass. — Bruce Rosenblum knows the drug Relyvrio won't save his life. It might not even ...

VIEW MORE : https://bit.ly/1breakingnews
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. - 1break
play
04:45

FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. - 1break
Breakthrough or risk FDA approves Alzheimer's drug
play
01:33

Breakthrough or risk FDA approves Alzheimer's drug
FDA Approves Asthma Drug to Mitigate Fatal Food Allergy Reactions
play
01:10

FDA Approves Asthma Drug to Mitigate Fatal Food Allergy Reactions
FDA approves first postpartum depression drug, Zurzuvae - 1breakingnews.com
play
00:23

FDA approves first postpartum depression drug, Zurzuvae - 1breakingnews.com
FDA approves new Alzheimer’s drug from Eli Lilly
play
01:30

FDA approves new Alzheimer’s drug from Eli Lilly
FDA approves drug to delay onset of Type 1 diabetes - 1breakingnews.com
play
02:04

FDA approves drug to delay onset of Type 1 diabetes - 1breakingnews.com
FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
play
00:23

FDA approves first ALS drug in 5 years after pleas from patients - 1breakingnews.com
FDA approves first COVID-19 drug: antiviral remdesivir, and other top stories in business from October 23, 2020.
play
00:51

FDA approves first COVID-19 drug: antiviral remdesivir, and other top stories in business from October 23, 2020.
FDA approves first COVID-19 drug - antiviral remdesivir, and other top stories in business from October 23, 2020.
play
00:51

FDA approves first COVID-19 drug - antiviral remdesivir, and other top stories in business from October 23, 2020.
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
01:56

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
FDA approves Litfulo, alopecia areata hair loss drug for teens 12+ - 1breakingnews.com
play
04:05

FDA approves Litfulo, alopecia areata hair loss drug for teens 12+ - 1breakingnews.com
US: FDA approves first cancer drug based on genetics of patient
play
01:55

US: FDA approves first cancer drug based on genetics of patient